Reproductive Plasticity in Oxytocin Neurons

催产素神经元的生殖可塑性

基本信息

项目摘要

DESCRIPTION (provided by applicant): Oxytocin (OT) functions as a hormone in labor and lactation and as a neuromodulator in the brain. OT receptors are present on OT neurons, which they autoregulate during somatodendritic OT release. During pregnancy and lactation, OT release is pulsatile, not continuous, and this pattern is critical to avoid OT receptor desensitization and insure proper hormone function at target smooth muscle in uterus and mammary gland. Neurons in the supraoptic (SON) and paraventricular nuclei (PVN) undergo remarkable plasticity during late pregnancy and lactation, including a glial-neuronal rearrangement and increases in synaptic activity. We have found enhanced spike afterhyperpolarizations (AHPs) during both periods. AHPs are critical in sculpting the short (~4 sec) high frequency (~50 Hz) bursts from OT neurons underlying this pulsatility, bursts that produce a bolus release of OT into the bloodstream to maximally contract uterine smooth muscle or mammary gland myoepithelium. Reproductive-associated plasticity in the SON and PVN depends on the pattern of ovarian steroid release during pregnancy and on the somatodendritic release of OT. We present the first in vivo evidence showing that central OT receptors are critical for the enhancement of the calcium-dependent AHPs normally manifest at late pregnancy. A specific OT antagonist administered chronically to the third ventricle during late pregnancy blocked this form of plasticity with no effect on VP neurons. In addition, we mimicked this plasticity by applying OT to hypothalamic slices from pregnant (E18-19) rats. The goal of this proposal is to understand the mechanisms of this adaptation made by OT neurons, and how it shapes OT neuronal firing to maximize hormone release and thereby insure normal parturition and lactation for infant development. Understanding the mechanisms of central OT receptor transduction at the OT neuron will have important applications for understanding the wider roles of OTRs in brain function. There are Three Specific Aims: Specific Aim 1. To determine if the enhancement of AHPs in OT neurons by OT is specific to OT neurons and OT receptor activation, whether it is specific to pregnant animals, and whether it is due to a change in the Ca2+ sensitivity of the underlying currents. Specific Aim 2. To test whether OT's effects on AHPs are mediated through a pERK 1/2-MAPK cascade, and whether it is associated with an increase expression of the AHP channels and/or the enzymes CK2 and PP2a, known to modulate AHP Ca2+ sensitivity. Specific Aim 3. To determine how enhanced AHPs modulate OT neuronal bursts, and to determine whether the reinsertion of missing excitatory activity differentially alters OT firing pattern in lactating vs. virgin rats, in an OT-dependent manner.
描述(由申请人提供):催产素(OT)在分娩和哺乳中作为激素发挥作用,在大脑中作为神经调质发挥作用。OT受体存在于OT神经元上,它们在体树突OT释放期间自动调节。在妊娠和哺乳期间,OT释放是脉动的,而不是连续的,这种模式对于避免OT受体脱敏和确保子宫和乳腺中靶平滑肌的适当激素功能至关重要。视上核(SON)和室旁核(PVN)中的神经元在妊娠晚期和哺乳期经历显著的可塑性,包括神经胶质-神经元重排和突触活动的增加。我们已经发现在这两个时期增强尖峰后超极化(AHPs)。AHPs在塑造来自OT神经元的短(~4秒)高频(~50 Hz)爆发中至关重要,这些爆发是这种脉动的基础,这些爆发产生OT向血流中的团注释放,以最大限度地收缩子宫平滑肌或乳腺肌上皮。 SON和PVN的生殖相关可塑性取决于妊娠期间卵巢类固醇释放的模式和OT的体树突释放。我们提出的第一个体内证据表明,中央OT受体是至关重要的钙依赖性AHPs的增强通常表现在怀孕后期。一个特定的OT拮抗剂长期管理的第三脑室在妊娠晚期阻断这种形式的可塑性,VP神经元没有影响。此外,我们通过将OT应用于妊娠(E18-19)大鼠的下丘脑切片来模仿这种可塑性。本提案的目标是了解OT神经元进行这种适应的机制,以及它如何塑造OT神经元放电以最大限度地释放激素,从而确保婴儿发育的正常分娩和哺乳。了解OT神经元的中枢OT受体转导机制对于理解OTR在脑功能中的更广泛作用具有重要的应用。有三个具体目标:具体目标1。确定OT引起的OT神经元AHPs增强是否特异于OT神经元和OT受体激活,是否特异于妊娠动物,以及是否是由于潜在电流的Ca 2+敏感性变化所致。具体目标2。为了测试OT是否对 AHP是通过pERK 1/2-MAPK级联介导的,并且它是否与已知调节AHP Ca 2+敏感性的AHP通道和/或酶CK 2和PP 2a的表达增加相关。具体目标3。确定增强的AHP如何调节OT神经元爆发,并确定缺失兴奋性活动的重新插入是否以OT依赖性方式差异性地改变哺乳期大鼠与未孕大鼠的OT放电模式。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM E ARMSTRONG其他文献

WILLIAM E ARMSTRONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM E ARMSTRONG', 18)}}的其他基金

Reproductive Plasticity in Oxytocin Neurons
催产素神经元的生殖可塑性
  • 批准号:
    8991713
  • 财政年份:
    2013
  • 资助金额:
    $ 31.13万
  • 项目类别:
Reproductive Plasticity in Oxytocin Neurons
催产素神经元的生殖可塑性
  • 批准号:
    8436841
  • 财政年份:
    2013
  • 资助金额:
    $ 31.13万
  • 项目类别:
Reproductive Plasticity in Oxytocin Neurons
催产素神经元的生殖可塑性
  • 批准号:
    8605206
  • 财政年份:
    2013
  • 资助金额:
    $ 31.13万
  • 项目类别:
A Confocal Laser Scanning Microscope for Neuroscience Imaging Center
用于神经科学成像中心的共焦激光扫描显微镜
  • 批准号:
    7790843
  • 财政年份:
    2010
  • 资助金额:
    $ 31.13万
  • 项目类别:
Plasticity of Oxytocin Neurons During Lactation
催产素神经元在哺乳期间的可塑性
  • 批准号:
    6638051
  • 财政年份:
    2001
  • 资助金额:
    $ 31.13万
  • 项目类别:
Plasticity of Oxytocin Neurons During Lactation
催产素神经元在哺乳期间的可塑性
  • 批准号:
    6920819
  • 财政年份:
    2001
  • 资助金额:
    $ 31.13万
  • 项目类别:
Plasticity of Oxytocin Neurons During Lactation
催产素神经元在哺乳期间的可塑性
  • 批准号:
    6773976
  • 财政年份:
    2001
  • 资助金额:
    $ 31.13万
  • 项目类别:
Plasticity of Oxytocin Neurons During Lactation
催产素神经元在哺乳期间的可塑性
  • 批准号:
    6536407
  • 财政年份:
    2001
  • 资助金额:
    $ 31.13万
  • 项目类别:
Plasticity of Oxytocin Neurons During Lactation
催产素神经元在哺乳期间的可塑性
  • 批准号:
    6364896
  • 财政年份:
    2001
  • 资助金额:
    $ 31.13万
  • 项目类别:
NEUROCHEMICAL INTERACTIONS AND OXYTOCIN NEURONS
神经化学相互作用和催产素神经元
  • 批准号:
    2205129
  • 财政年份:
    1996
  • 资助金额:
    $ 31.13万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 31.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 31.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 31.13万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 31.13万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 31.13万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 31.13万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 31.13万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 31.13万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 31.13万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 31.13万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了